Summary
-
1.
The influence of angiotensin on the isolated rabbit heart perfused at constant pressure or constant flow was investigated at rest and during electrical stimulation of the postganglionic sympathetic nerves.
-
2.
In low concentrations (32–100ng/min or 1.4–5.3 ng/ml) angiotensin had considerable positive inotropic effects, while its chronotropic effects were weak and variable. High concentrations decreased the rate of beat, and an increase in the height of contraction was preceded by a transient phase of inhibition. In hearts perfused at constant pressure, angiotensin diminished coronary flow. The positive inotropic effect of angiotensin was not accompanied by the appearance of increased amounts of noradrenaline in the venous effluent.
-
3.
Angiotensin caused a dose-dependent increase in the output of noradrenaline induced by sympathetic nerve stimulation. The peptide was most potent in hearts perfused at constant flow; the threshhold dose of angiotensin for this procedure was 3.2 ng/min (128 pg/ml), and maximal effects (i.e., an increase by 81%) were observed with 32 ng/min (1.28 ng/ml). Doses about three times higher were required to obtain similar effects in hearts perfused at constant pressure. The reduction of coronary flow as seen under these conditions may be responsible for the weaker effect of angiotensin. Continuous infusion increased the output of noradrenaline during several successive stimulation periods.
-
4.
In most cases, the increase in output of noradrenaline induced by angiotensin did not lead to an increase in the response of the pacemaker or of the myocardium to sympathetic stimulation. Only in hearts perfused at constant flow during infusion of 32 ng/min of angiotensin the positive inotropic effect of sympathetic stimulation was significantly augmented.
-
5.
The results indicate that angiotensin may modulate the activity of the autonomic nervous system by influencing peripheral sympathetic nerves.
Similar content being viewed by others
Literatur
Aiken, J. W., Reit, E.: Stimulation of the cat stellate ganglion by angiotensin. J. Pharmacol. exp. Ther.159, 107–114 (1968).
Berry, W. B., Austen, W. G., Clark, W. D.: Studies on the relative cardiac and peripheral actions of angiotensin. Ann. Surg.159, 520–528 (1964).
Bianchi, A., de Schaepdryver, A. F., de Vleeschhouwer, G. R., Preziosi, P.: On the pharmacology of synthetic hypertensin. Arch. int. Pharmacodyn.124, 21–44 (1960).
Bickerton, R. K., Buckley, J. P.: Evidence for a central mechanism in angiotensin induced hypertension. Proc. Soc. Exp. Biol. (N. Y.)106, 834–836 (1961).
Buckley, J. P.: Effects of synthetic angiotensin II on catecholamine levels and biological activity. Acta physiol. scand.65, 273–278 (1966).
Cranston, W. I., Lavery, H., Lowe, R. D., Rosendorff, C.: The central pressor effect of angiotensin in the rabbit. J. Physiol. (Lond.)198, 30–31 P (1968).
Euler, U. S. v., Floding, I.: A fluorimetric micromethod for differential estimation of adrenaline and noradrenaline. Acta phvsiol. soand.33, Suppl. 118, 45–56 (1955).
Farr, W. C., Grupp, G.: Sympathetically mediated effects of angiotensin on the dog heart in situ. J. Pharmacol. exp. Ther.156, 528–537 (1967).
Feldberg, W., Lewis, G. P.: The action of peptides on the adrenal medulla. Release of adrenaline by bradykinin and angiotensin. J. Physiol. (Lond.)171, 98–108 (1964).
Finkielman, S., Worcel, M., Massani, Z. M., Nahmod, V. E., Paladini, A. C., Agrest, A.: Angiotensin blood levels in hypovolemic shock during osmotic diuresis. Amer. J. Physiol.215, 308–313 (1968).
Fowler, N. O., Holmes, J. C.: Coronary and myocardial action of angiotensin. Circulat. Res.14, 191–201 (1964).
Haefely, W., Hürlimann, A., Thoenen, H.: Effects of bradykinin and angiotensin on ganglionic transmission. Biochem. Pharmacol.14, 1393 (1965).
Heeg, E., Meng, K.: Die Wirkung des Bradykinins, Angiotensins und Vasopressins auf Vorhof, Papillarmuskel und isoliert durchströmte Herzpräparate des Meerschweinchens. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.250, 35–41 (1965).
Hughes, I. E.: Chronotropic and pressor responses to angiotensin in rats anesthetised with urethane. Eur. J. Pharmacol.3, 189–195 (1968).
Huković, S., Muscholl, E.: Die Noradrenalin-Abgabe aus dem isolierten Kaninchenherzen bei sympathischer Nervenreizung und ihre pharmakologische Beeinflussung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.244, 81–96 (1962).
Iversen, L. L.: The uptake and storage of noradrenaline in sympathetic nerves. Cambridge: The University Press 1967.
James, T. N.: Absence of direct chronotropic action of angiotensin infused into the sinus node artery. Amer. J. Physiol.209, 571–576 (1965).
Koch-Weser, J.: Nature of the inotropic action of angiotensin on ventricular myocardium. Circulat. Res.16, 230–237 (1965).
Krasney, J. A., Hogan, P. M., Lowe, R. F., Youmans, W. B.: Peripheral adrenergic basis for cardioaccelerator action of angiotensin. Amer. J. Physiol.211, 1447 to 1450 1966
—, Paudler, P. T., Smith, D. C., Davis, L. D., Youmans, W. B.: Mechanisms of cardioaccelerator action of angiotensin. Amer. J. Physiol.209, 539–544 (1965).
Kuschinsky, G., Lüllmann, H.: Über die Wirkung von synthetischem Hypertensin auf Kammer- und Vorhofsmuskulatur der Katze. Klin. Wschr.37, 928–931 (1959).
Lewis, G. P., Reit, E.: The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J. Physiol. (Lond.)179, 538–553 (1965).
Liebau, H., Distler, A., Wolff, H. P.: Untersuchungen zur indirekten sympathomimetischen Wirkung von Angiotensin an isolierten Blutgefäßen. Klin. Wschr.44, 322–326 (1966).
Massani, Z. M., Finkielman, S., Worcel, M., Agrest, A., Paladini, A. C.: Angiotensin blood levels in hypertensive and nonhypertensive diseases. Clin. Sci.30, 473 to 483 (1966).
McCubbin, J. W., Page, I. H.: Renal pressor system and neurogenic control of arterial pressure. Circulat. Res.12, 553–559 (1963).
Meier, R., Tripod, J., Studer, A.: Comparaison des propriétés vasculaires périphériques de l'hypertensine synthétique et de divers vasoconstricteurs. Arch. int. Pharmacodyn.117, 185–196 (1958).
Palaic, D., Khairallah, P. A.: Inhibition of noradrenaline uptake by angiotensin. J. Pharm. Pharmacol.19, 396–397 (1967a).
— —: Effect of angiotensin on uptake and release of norepinephrine by brain. Biochem. Pharmacol.16, 2291–2298 (1967b).
— —: Inhibition of norepineprine re-uptake by angiotensin in brain. J. Neurochem.15, 1195–1202 (1968).
Pals, D. T., Masucci, P. D.: Effect of cocaine, desipramine, and angiotensin on uptake of noradrenaline in tissues of pithed rats. Nature (Lond.)217, 772–773 (1968).
Panisset, J. C., Bourdois, P.: Effect of angiotensin on the responses to noradrenaline and sympathetic nerve stimulation, and on3H-noradrenaline uptake in cat mesenteric blood vessels. Can. J. Physiol. Pharmacol.46, 125–131 (1968).
Peach, M. J., Ford, G. D.: The actions of angiotensin II on canine myocardial and plasma catecholamines. J. Pharmacol. exp. Ther.162, 92–100 (1968).
Ross, G., White, P. N.: Role of catecholamines in cardiovascular responses to angiotensin. Amer. J. Physiol.211, 1419–1423 (1966).
Schumann, H. J., Güther, W.: Untersuchungen zum Wirkungsmechanismus von Angiotensin am isolierten Aortenpräparat und am Blutdruck von Ratten und Meerschweinchen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.256, 169–182 (1967).
Staszewska-Barczak, J., Vane, J. R.: The release of catecholamines from the adrenal medulla by peptides. Brit. J. Pharmacol.30, 655–667 (1967).
Thoenen, H., Hürlimann, A., Haefely, W.: The effect of angiotensin on the response to postganglionic sympathetic stimulation of the cat spleen: lack of facilitation of norepinephrine liberation. Med. Pharmacol. exp.13, 379–385 (1965).
Walter, P., Bassenge, E.: Effect of angiotensin on vascular smooth muscle. Pflügers Arch.307, 70–82 (1969).
Zimmerman, B. G.: Effect of acute sympathectomy on responses to angiotensin and norepinephrine. Circulat. Res.11, 780–787 (1962).
—: Evaluation of peripheral and central components of action of angiotensin on the sympathetic nervous system. J. Pharmacol. exp. Ther.158, 1–10 (1967).
—, Gisslen, J.: Pattern of renal vasoconstriction and transmitter release during sympathetic stimulation in presence of angiotensin and cocaine. J. Pharmacol. exp. Ther.163, 320–329 (1968).
—, Whitmore, L.: Effects of angiotensin and phenoxybenzamine on release of norepinephrine in vessels during sympathetic nerve stimulation. Int. J. Neuropharmacol.6, 27–38 (1967).
Author information
Authors and Affiliations
Additional information
Ausgeführt mit Unterstützung der Deutschen Forschungsgemeinschaft.
Frl. B. Rawe und Herrn J. Urban danken wir für ihre sorgfältige Mitarbeit.
Rights and permissions
About this article
Cite this article
Starke, K., Werner, U. & Schümann, H.J. Wirkung von Angiotensin auf Funktion und Noradrenalinabgabe isolierter Kaninchenherzen in Ruhe und bei Sympathicusreizung. Naunyn-Schmiedebergs Arch. Pharmak. 265, 170–186 (1969). https://doi.org/10.1007/BF00997149
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00997149